<DOC>
	<DOC>NCT01436591</DOC>
	<brief_summary>The primary endpoint of this study is to show that this algorithm in high definition is superior to the classical algorithm in the diagnosis of lymph node metastases.</brief_summary>
	<brief_title>Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Informed consent and signed by the patient Age ≥ 18 years Breast tumor for which the therapeutic indication for surgery has from the outset: breast surgery (conservative or radical) associated with a conventional axillary dissection Proof of infiltrating ductal carcinoma histology No known metastasis No consindication to anesthesia. Exclusion criteria: History of neoadjuvant therapy Patients with invasive lobular carcinoma Indication of the use of sentinel node (if invasive carcinoma unicentric, ≤ 2 cm in diameter, without palpable lymphadenopathy (N0)) Diabetes is not controlled by conventional treatment (blood glucose&gt; 1.8 g / l) Inability to capital Patients who are pregnant or nursing or of childbearing potential and not using adequate contraception Persons deprived of their liberty Major subject of a measure of legal protection or unable to consent Refusal to participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Breast</keyword>
	<keyword>18FDG</keyword>
	<keyword>Axillary</keyword>
	<keyword>Positron Emission Tomography</keyword>
</DOC>